[1]
“PHARMACOKINETIC VARIABILITY AND THERAPEUTIC DRUG MONITORING OF SYSTEMIC ANTIFUNGAL AGENTS: MITIGATING HEPATOTOXICITY AND OPTIMIZING EFFICACY IN CRITICALLY ILL COHORTS”, Wor.Bul.Pub.Helt., vol. 56, pp. 85–88, Mar. 2026, Accessed: Apr. 18, 2026. [Online]. Available: https://www.scholarexpress.net/index.php/wbph/article/view/5984